Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Rosuvastatin, Rosuvastatin Calcium. Patients taking Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Major: 2

Major (2)

Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir + Rosuvastatin— Combination increases rosuvastatin exposure. Limit rosuvastatin dose to 10 mg once daily.
Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir + Rosuvastatin Calcium— Increases rosuvastatin exposure. Limit rosuvastatin dose to 10 mg once daily.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.